The roles of different types of serotonin receptors in activation of the hypophyseal-testicular complex induced in mice by the presence of a female

被引:10
作者
Amstislavskaya T.G. [1 ]
Popova N.K. [1 ]
机构
[1] Behavioral Phenogenetics Laboratory, Institute of Cytology and Genetics, Russian Academy of Sciences, Novosibirsk
关键词
Ondansetron; Ketanserin; Receptive Female; Plasma Testosterone Level; Blood Testosterone;
D O I
10.1023/B:NEAB.0000038136.27999.3d
中图分类号
学科分类号
摘要
Placing of receptive females in the sector of a cage separated by a partition preventing physical contact but allowing sight and olfaction induced increases in blood testosterone levels in male mice. The selective agonist of 5-HT1A receptors 8-OH-DPAT (0.1 mg/kg) and the mixed 5-HT1A/1B receptor agonist eltoprazine (3.0 and 10.0 mg/kg) blocked the activatory effect of presentation of females on the hypothalamo-hypophyseal-testicular complex (HHTC) in males, while the 5-HT1A receptor antagonist p-MPPI (0.2 mg/kg) prevented the inhibitory effects of 8-OH-DPAT and eltoprazine. The 5-HT1B receptor agonist CGS-12066A (1.0 and 2.0 mg/kg) had no effect, while the mixed 5-HT1B/2C agonist TFMPP (5.0 mg/kg) blocked the increase in blood testosterone in males in response to presentation of females. The 5-HT2A receptor antagonist ketanserin (1.0 and 2.0 mg/kg) prevented the increase in testosterone induced by the presence of females. The 5-HT3 receptor antagonist ondansetron (0.05 and 0.1 mg/kg) increased the initial plasma testosterone level but blocked activation of the HHTC induced by the presence of receptive females. These results led to the conclusion that 5-HT receptors are involved in controlling the sexual activation of males. Different types and even subtypes of the same type of 5-HT receptor had different effects, both inhibitory and activatory, on activation of the HHTC by receptive females. Blockade of HHTC activation induced by the presence of females appears to involve 5-HT1A and 5-HT2C receptors, while activation involves 5-HT2A and 5-HT3 receptors. © 2004 Plenum Publishing Corporation.
引用
收藏
页码:833 / 837
页数:4
相关论文
共 15 条
  • [1] Amstislavskaya T.G., Osadchuk A.V., Naumenko E.V., Probl. Éndokrinol., 35, 6, pp. 63-66, (1989)
  • [2] Novikov S.N., Pheromones and Reproduction in Mammals, (1988)
  • [3] Osadchuk A.V., Naumenko E.V., Dokl. Akad. Nauk SSSR, 258, 3, pp. 746-749, (1981)
  • [4] Popova N.K., Amstislavskaya T.G., Kucheryavyi S.A., Zh. Vyssh. Nerv. Deyat., 48, 1, pp. 84-90, (1998)
  • [5] Ahlenius S., Larsson K., Wijkstrom A., Eur. J. Pharmacol., 210, 2-3, pp. 259-266, (1991)
  • [6] Barnes N.M., Sharp T., Neuropharmacology, 39, 8, pp. 1083-1152, (1999)
  • [7] Baxter G., Kennett G., Blaney F., Blackburn T., Trends Pharmacol. Sci., 16, 3, pp. 105-110, (1995)
  • [8] Griebel G., Pharmacol. Ther., 65, pp. 319-395, (1995)
  • [9] Hoyer D., Clarke D.E., Fozard J.R., Et al., Pharmacol. Rev., 46, 2, pp. 157-200, (1994)
  • [10] Kung M.P., Frederick D., Mu M., Et al., J. Pharmacol. Exptl. Ther., 272, pp. 429-437, (1995)